Role of sFLT-1/PlGF ratio in predicting severe adverse materno-fetal outcome in high risk women
- 1 December 2022
- journal article
- research article
- Published by Elsevier BV in Pregnancy Hypertension
- Vol. 30, 154-160
- https://doi.org/10.1016/j.preghy.2022.10.003
Abstract
No abstract availableKeywords
Funding Information
- Roche
This publication has 17 references indexed in Scilit:
- Angiogenic Factor Estimation as a Warning Sign of Preeclampsia-Related Peripartum Morbidity Among Hospitalized PatientsHypertension, 2019
- Preeclampsia and HELLP syndrome, the role of the liverThe Journal of Maternal-Fetal & Neonatal Medicine, 2019
- Association of antepartum blood pressure levels and angiogenic profile among women with chronic hypertensionPregnancy Hypertension, 2018
- Consensus definition of fetal growth restriction: a Delphi procedureUltrasound in Obstetrics & Gynecology, 2016
- Less-Tight versus Tight Control of Hypertension in PregnancyThe New England Journal of Medicine, 2015
- Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocolBMC Pregnancy and Childbirth, 2014
- Risk of Adverse Pregnancy Outcomes in Women With Mild Chronic Hypertension Before 20 Weeks of GestationObstetrics & Gynecology, 2014
- Global and regional estimates of preeclampsia and eclampsia: a systematic reviewEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
- Prediction of pre‐eclampsia by uterine artery Doppler imaging: relationship to gestational age at delivery and small‐for‐gestational ageUltrasound in Obstetrics & Gynecology, 2008
- Circulating Angiogenic Factors and the Risk of PreeclampsiaThe New England Journal of Medicine, 2004